Search clinical trials for: Antineoplastic Immune Cell

Total 71964 results

Incyte Corporation

Completed

A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy

Cytokine Release Syndrome

United States
Ivy Life Sciences, Co., Ltd
Tri-Service General Hospital

Unknown

Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy

Liver Cancer | HepatoCellular Carcinoma

Taiwan
Richard Burt, MD

Terminated

Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease

CROHN'S DISEASE

United States
Northwestern University

Completed

Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study

Systemic Lupus Erythematosus

United States
Shenzhen Geno-Immune Medical Institute

Unknown

Immunotherapy Treating GI Cancer

Cancer

China
Richard Burt, MD

Terminated

Stem Cell Support in Patients With Rheumatoid Arthritis

RHEUMATOID ARTHRITIS

United States
Cellular Biomedicine Group Ltd.
Fudan University

Unknown

Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC

Metastatic Castration-resistant Prostate Cancer

China
Shenzhen Geno-Immune Medical Institute

Unknown

Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells

Cancer

China
Ivy Life Sciences, Co., Ltd
Taipei Veterans General Hospital, Taiwan; Tri-Service General Hospital

Completed

A Study to Evaluate the Safety and Efficacy of Ex Vivo Expanded Autologous Immune Killer Cells (IKC) in Stage IV Non-small Cell Lung Cancer (NSCLC) in Patients Who Failed Chemotherapy or Target Therapy (IVY03)

Non-small Cell Lung Cancer (NSCLC) Stage IV

Taiwan
Pell Bio-Med Technology Co., Ltd.

Recruiting

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

Diffuse Large B Cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Large B-cell Lymphoma | Follicular Lymphoma Grade 3B | Follicular Lymphoma Grade 3A

Taiwan
Baylor College of Medicine
National Cancer Institute (NCI); Stand Up To Cancer; Center for Cell and Gene... and other collaborators

Recruiting

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

Sarcoma | Soft Tissue Sarcoma | Osteosarcoma | Ewing Sarcoma | Rhabdomyosarcoma | Synovial Sarcoma | HER-2 Protein Overexpression | Undifferentiated Sarcoma

United States
Royan Institute

Completed

Evaluate the Effect of Bone Marrow Derived Cd133+ Cells in Patient With Osteonecrosis of Femoral Head

Osteonecrosis

Iran, Islamic Republic of
Pharmicell Co., Ltd.

Terminated

Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC-PC)

Castration Resistant Prostate Cancer, CRPC

Korea, Republic of
Korea Cancer Center Hospital

Terminated

A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer

Uterine Cervical Neoplasms

Korea, Republic of
Poitiers University Hospital

Completed

Immunosuppression's Long Term Impact on Anti-tumoral Oversight in Kidney Transplantation

Kidney Transplant; Complications

France
Joseph C. Wu
California Institute for Regenerative Medicine (CIRM)

Recruiting

Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy for Chronic Ischemic Left Ventricular Dysfunction (HECTOR)

Chronic Ischemic Left Ventricular Dysfunction

United States
TrichoScience Innovations, Inc.
PRA Health Sciences; Pharmalog Institut für klinische Forschung GmbH (PHARMALOG... and other collaborators

Completed

Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia

Androgenetic Alopecia

Georgia
Stanford University

Withdrawn

Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal Cancer

Colorectal Neoplasms | Anal, Colon, and Rectal Cancers

United States
Amgen

Active, not recruiting

AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).

Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation

Taiwan, Hong Kong
University College, London

Unknown

Autologous Stem Cells in Achilles Tendinopathy (ASCAT)

Tendinopathy | Achilles Tendinitis | Achilles Degeneration | Achilles Tendinitis, Right Leg | Achilles Tendon Thickening | Achilles Tendinitis, Left Leg

United Kingdom
West Cancer Center
Puma Biotechnology, Inc.; Celcuity Inc

Active, not recruiting

Evaluating the Efficacy of Neratinib on Live Cell HER2 Signaling Transduction Analysis Positive Triple Negative Breast (FACT-2)

Triple Negative Breast Cancer | HER2-positive Breast Cancer | Early-stage Breast Cancer

United States
ImmuneSensor Therapeutics Inc.

Completed

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Solid Tumor, Adult

United States
Leiden University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Unknown

Stem Cell Therapy to Improve the Muscle Function of Patients With Partly Denervated Muscles of the Arm

Brachial Plexus Injury

Netherlands
Zhongnan Hospital

Recruiting

Clinical Study of MAK Immune Cells in the Treatment of PHC

Primary Hepatocellular Carcinoma

China
Neuromed IRCCS

Unknown

Targeting Potassium Channels to Reprogram Glioblastoma Microenvironment: in Vitro and in Vivo Studies

Cancer of Head and Neck

Italy
Duke University
University of Wisconsin, Madison

Recruiting

Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)

Carcinoma, Renal Cell | Carcinoma, Urothelial

United States
Hangzhou Converd Co., Ltd.
The Second Hospital of Jia Xing

Unknown

Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Gastrointestinal Cancer

Gastrointestinal Cancer
Samuel Strober
California Institute for Regenerative Medicine (CIRM)

Recruiting

Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation (CIRM)

Immune Tolerance

United States
Johann Wolfgang Goethe University Hospital

Completed

Safety and Feasibility Study of Autologous Bone Marrow Cell Transplantation in Patients With Peripheral Arterial Occlusive Disease (PAOD)

Arterial Occlusive Diseases

Germany
Laura Johnston
National Institutes of Health (NIH)

Completed

Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD

Graft Versus Host Disease | Allogeneic Hematopoietic Cell Transplant Recipient

United States
James Baumgartner, MD
CBR Systems, Inc.

Completed

Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss

Sensorineural Hearing Loss

United States
Losordo, Douglas, M.D.

Completed

Stem Cell Study for Patients With Heart Disease

Myocardial Ischemia | Chest Pain | Heart Disease | Angina | Coronary Arterial Disease (CAD)

United States
Cellatoz Therapeutics, Inc

Active, not recruiting

The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease.

Charcot Marie Tooth Disease, Type 1

Korea, Republic of
National Cancer Centre, Singapore
Bristol-Myers Squibb

Recruiting

Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC

Hepatocellular Carcinoma | Colorectal Cancer | Liver Metastases | Colorectal Carcinoma | Hepatocellular Cancer

Singapore
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Completed

Nivolumab With Epstein Barr Virus Specific T Cells (EBVSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE) (PREVALE)

Lymphoproliferative Disorders | Hodgkin Lymphoma | EBV Related Non-Hodgkin's Lymphoma | NonHodgkin Lymphoma | EBV-Related PTLD | EBV Related Lymphoma | EBV Related Hodgkin's Lymphoma

United States
Sheng Hu
Wuhan Binhui Biotechnology Co., Ltd.

Recruiting

Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion

Malignant Pleural Effusion | Malignant Peritoneal Effusion

China
University of Exeter
King's College London; Benaroya Research Institute; Royal Devon and Exeter NHS...

Recruiting

EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study) (EXE-T1D)

Type1 Diabetes Mellitus

Netherlands, United States, United Kingdom
City of Hope Medical Center
National Cancer Institute (NCI); CytoImmune Therapeutics

Active, not recruiting

Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors

Metastatic Lung Non-Small Cell Carcinoma | Refractory Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer... and other conditions

United States
Zhejiang University
UTC Therapeutics Inc.

Recruiting

UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

Mesothelin-positive Advanced Malignant Solid Tumors

China
Peking University
Shanghai Ming Ju Biotechnology Co., Ltd.

Recruiting

MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors

Advanced Solid Tumor

China
Zhujiang Hospital

Not yet recruiting

Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCS

Recurrence | Hepatocellular Carcinoma | Surgery | Circulating Tumor Cell

China
Throne Biotechnologies Inc.

Not yet recruiting

Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19

Severe Acute Respiratory Syndrome (SARS) Pneumonia
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Terminated

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Minimal Residual Disease | Therapy-Related Acute Myeloid Leukemia | Therapy-Related Myelodysplastic... and other conditions

United States
Dana-Farber Cancer Institute

Completed

Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials

Non-Hodgkin's Lymphoma

United States
University Hospitals Cleveland Medical Center
Case Western Reserve University

Recruiting

Impact of Mesenchymal Stem Cells in Knee Osteoarthritis

Musculoskeletal Pain | Knee Osteoarthritis | Cartilage Injury | Cartilage Degeneration

United States
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Unknown

INFUSION OF ALLOREACTIVE NATURAL KILLER (NK) CELLS AS CONSOLIDATION STRATEGY FOR ACUTE MYELOID LEUKEMIA PATIENTS (NKAML)

Adult Acute Myeloid Leukemia in Remission

Italy
University of Liege

Completed

Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease

Hematological Malignancies

Belgium
University of California, Irvine
University of California, San Diego

Withdrawn

Autologous Cell Therapy After Stroke

Stroke

United States
China Medical University, China

Not yet recruiting

Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma

PD-1 Antibody | Gastrointestinal Tumours | DC-Cell | NK-Cell
University of Cologne

Not yet recruiting

Immun Response in Children With MIS-C

MIS-C Multisystem Inflammatory Syndrome in Children

Germany

Search clinical trials for: Antineoplastic Immune Cell

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations